163521-19-5,
5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxylic acid,
Vilazodone Carboxylic acid,
5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-Benzofurancarboxylic acid,
5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}benzofuran-2-carboxylic acid,
RSXUEYFLDNUILS-UHFFFAOYSA-N,
VilazodoneCarboxylicacid,
UNII-93K783WZV4,
SCHEMBL2162650,
CTK8B9653,
DTXSID70458579,
93K783WZV4,
BCP12355,
CS-M1885,
KS-00001FF4,
8307AA,
ANW-62848,
MFCD09833264,
ZINC22010763,
AKOS016004184,
AJ-80440,
CS-14419,
DA-18280,
AX8233140,
TC-151593,
FT-0705778,
1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carboxybenzofuran-5-yl)piperazine,
cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-Benzofurancarboxylic acid,
2-Benzofurancarboxylic acid, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-,
5-{4-[4-(5-Cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxylic acid,
5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid|||Vilazodone intermediate,
Vilazodone,
C26H26N4O3,
CS-O-08433,
CID11201569,
5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxylic Acid,